ASHLEY ALONSO: Open Payments
NPI 1609262104 · HAYS, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 21 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $599 · 2025 $488
Food & beverage: $413Education: $75
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $107 |
| Lilly USA, LLC | 2 | $60 |
| ABBVIE INC. | 3 | $53 |
| PFIZER INC. | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Intercept Pharmaceuticals, Inc. | 2 | $35 |
| GENZYME CORPORATION | 1 | $33 |
| QOL Medical, LLC | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: TREMFYA, OMVOH, DUPIXENT, XIFAXAN, VOQUEZNA, VELSIPITY, OCALIVA, RINVOQ.
Industry payments across KS — which companies pay providers there.
